Literature DB >> 10212276

A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae.

D L Hogue1, L Kerby, V Ling.   

Abstract

Mouse transporter protein (MTP) is a highly conserved polytopic membrane protein present in mammalian lysosomes and endosomes. The role of MTP in regulating the in vivo subcellular distribution of numerous structurally distinct small molecules has been examined in this study by its expression in a drug-sensitive strain of the yeast Saccharomyces cerevisiae. Surprisingly, the expression of MTP in membranes of an intracellular compartment resulted in a cellular resistance or hypersensitivity to a range of drugs that included nucleoside and nucleobase analogs, antibiotics, anthracyclines, ionophores, and steroid hormones. The intracellular bioavailability of steroid hormones was altered by MTP, as determined using an in vivo glucocorticoid receptor-driven reporter assay in yeast, suggesting that the MTP-regulated drug sensitivity arose due to a change in the subcellular compartmentalization of steroid hormones and other drugs. MTP-regulated drug sensitivity in yeast was blocked to varying degrees by compounds that inhibit lysosomal function, interfere with intracellular cholesterol transport, or modulate the multidrug resistance phenotype of mammalian cells. These results indicate that MTP is involved in the subcellular compartmentalization of diverse hydrophobic small molecules and contributes to the inherent drug sensitivity or resistance of the mammalian cell.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212276     DOI: 10.1074/jbc.274.18.12877

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Lysosome-associated protein transmembrane 4 alpha (LAPTM4 alpha) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes.

Authors:  Douglas L Hogue; Colin Nash; Victor Ling; Tom C Hobman
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.

Authors:  Xin-Rong Liu; Rou-Li Zhou; Qing-Yun Zhang; Ye Zhang; Yue-Ying Jin; Ming Lin; Jing-An Rui; Da-Xiong Ye
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

3.  LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages.

Authors:  Wioletta K Glowacka; Philipp Alberts; Rika Ouchida; Ji-Yang Wang; Daniela Rotin
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

4.  Identification of human gene products containing Pro-Pro-x-Tyr (PY) motifs that enhance glutathione and endocytotic marker uptake in yeast.

Authors:  Shujie Shi; Sylvia Notenboom; Mark E Dumont; Nazzareno Ballatori
Journal:  Cell Physiol Biochem       Date:  2010-01-12

5.  LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV.

Authors:  Silvia Vergarajauregui; Jose A Martina; Rosa Puertollano
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

6.  LAPTM4A interacts with hOCT2 and regulates its endocytotic recruitment.

Authors:  A Grabner; S Brast; S Sucic; S Bierer; B Hirsch; H Pavenstädt; H H Sitte; E Schlatter; G Ciarimboli
Journal:  Cell Mol Life Sci       Date:  2011-05-08       Impact factor: 9.261

7.  LAPTM4B facilitates late endosomal ceramide export to control cell death pathways.

Authors:  Tomas Blom; Shiqian Li; Andrea Dichlberger; Nils Bäck; Young Ah Kim; Ursula Loizides-Mangold; Howard Riezman; Robert Bittman; Elina Ikonen
Journal:  Nat Chem Biol       Date:  2015-08-17       Impact factor: 15.040

Review 8.  Comparative molecular biological analysis of membrane transport genes in organisms.

Authors:  Toshifumi Nagata; Shigemi Iizumi; Kouji Satoh; Shoshi Kikuchi
Journal:  Plant Mol Biol       Date:  2008-02-22       Impact factor: 4.076

9.  LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Hua Yang; Fu Xia Xiong; Ming Lin; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-19       Impact factor: 4.553

10.  Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.

Authors:  Yang Li; Lihua Zou; Qiyuan Li; Benjamin Haibe-Kains; Ruiyang Tian; Yan Li; Christine Desmedt; Christos Sotiriou; Zoltan Szallasi; J Dirk Iglehart; Andrea L Richardson; Zhigang Charles Wang
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.